Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by J. Pöhlmann
Pdb74 - Ideglira Versus Iglarlixi for Patients With Inadequately Controlled Type 2 Diabetes on Basal Insulin: A Long-Term Cost-Effectiveness Analysis in the Czech Republic
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
An Indirect Treatment Comparison of the Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine/Lixisenatide (iGlarLixi) in Patients With Type 2 Diabetes Uncontrolled on Basal Insulin
Journal of Medical Economics
Health Policy
Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin or Exenatide in Patients With Inadequately Controlled Type 2 Diabetes on Oral Antidiabetic Drugs in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes Receiving Basal–Bolus Therapy
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-On Therapy in Chinese Patients With Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pdb67 - Once-Weekly Semaglutide Versus Dulaglutide for the Treatment of Patients With Type 2 Diabetes in Portugal: A Long-Term Cost-Effectiveness Analysis Based on Sustain 7
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Benefit of Basal Insulin Analogue Treatment in Persons With Type 2 Diabetes Inadequately Controlled on Prior Insulin Therapy: A Prospective, Noninterventional, Multicenter Study
Diabetes Therapy
Internal Medicine
Endocrinology
Metabolism
Diabetes
Efficacy and Safety of Three-Times-Daily Versus Twice-Daily Biphasic Insulin Aspart 30 in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Combined With Oral Antidiabetic Drugs
Diabetes Research and Clinical Practice
Internal Medicine
Endocrinology
Metabolism
Medicine
Diabetes
Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden
Applied Health Economics and Health Policy
Medicine
Health Policy
Economics
Econometrics
Pdb64 - Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients With Type 2 Diabetes
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
